Belpointe Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-100	Closed	-$1.88K	–	629
2023 Q1	$1.88K	Hold	100	–	–	﹤0.01%	3318
2022 Q4	$1.59K	Buy	+100	New	+$1.59K	﹤0.01%	3330